Insider Transactions in Q2 2021 at G1 Therapeutics, Inc. (GTHX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 29
2021
|
Seth Rudnick |
SELL
Open market or private sale
|
Direct |
10,000
-69.5%
|
$220,000
$22.35 P/Share
|
|
Jun 29
2021
|
Seth Rudnick |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+25.79%
|
$0
$0.35 P/Share
|
|
Jun 17
2021
|
Willie A Deese |
BUY
Grant, award, or other acquisition
|
Direct |
4,389
+50.0%
|
-
|
|
Jun 17
2021
|
Glenn P Muir |
BUY
Grant, award, or other acquisition
|
Direct |
4,389
+2.44%
|
-
|
|
Jun 17
2021
|
Garry A Nicholson |
BUY
Grant, award, or other acquisition
|
Direct |
4,389
+50.0%
|
-
|
|
Jun 17
2021
|
Seth Rudnick |
BUY
Grant, award, or other acquisition
|
Direct |
4,389
+50.0%
|
-
|
|
Jun 17
2021
|
Cynthia Schwalm |
BUY
Grant, award, or other acquisition
|
Direct |
4,389
+42.7%
|
-
|
|
Jun 17
2021
|
Mark A. Velleca |
SELL
Open market or private sale
|
Direct |
10,000
-14.08%
|
$210,000
$21.77 P/Share
|
|
Jun 17
2021
|
Mark A. Velleca |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.35%
|
$0
$0.39 P/Share
|
|
Jun 16
2021
|
Mark A. Velleca |
SELL
Open market or private sale
|
Direct |
10,000
-14.08%
|
$210,000
$21.74 P/Share
|
|
Jun 16
2021
|
Mark A. Velleca |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.35%
|
$0
$0.39 P/Share
|
|
Jun 15
2021
|
Mark A. Velleca |
SELL
Open market or private sale
|
Direct |
10,000
-14.08%
|
$220,000
$22.39 P/Share
|
|
Jun 15
2021
|
Mark A. Velleca |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.35%
|
$0
$0.39 P/Share
|
|
May 25
2021
|
Mark A. Velleca |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+24.69%
|
$0
$0.39 P/Share
|
|
May 13
2021
|
Mark A. Velleca |
SELL
Open market or private sale
|
Direct |
10,000
-19.61%
|
$200,000
$20.54 P/Share
|
|
May 13
2021
|
Mark A. Velleca |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+16.39%
|
$0
$0.39 P/Share
|
|
May 12
2021
|
Mark A. Velleca |
SELL
Open market or private sale
|
Direct |
10,000
-19.61%
|
$200,000
$20.07 P/Share
|
|
May 12
2021
|
Mark A. Velleca |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+16.39%
|
$0
$0.39 P/Share
|
|
May 11
2021
|
Mark A. Velleca |
SELL
Open market or private sale
|
Direct |
10,000
-19.61%
|
$190,000
$19.1 P/Share
|
|
May 11
2021
|
Mark A. Velleca |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+16.39%
|
$0
$0.39 P/Share
|
|
May 10
2021
|
Rajesh Malik Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+15.8%
|
$0
$0.3 P/Share
|
|
Apr 22
2021
|
Rajesh Malik Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-25.73%
|
$330,000
$22.07 P/Share
|
|
Apr 22
2021
|
Rajesh Malik Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+20.46%
|
$0
$0.39 P/Share
|
|
Apr 15
2021
|
Mark A. Velleca |
SELL
Open market or private sale
|
Direct |
10,000
-19.61%
|
$240,000
$24.96 P/Share
|
|
Apr 15
2021
|
Mark A. Velleca |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+16.39%
|
$0
$0.39 P/Share
|
|
Apr 14
2021
|
Mark A. Velleca |
SELL
Open market or private sale
|
Direct |
10,000
-19.61%
|
$240,000
$24.53 P/Share
|
|
Apr 14
2021
|
Mark A. Velleca |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+16.39%
|
$0
$0.39 P/Share
|
|
Apr 13
2021
|
Mark A. Velleca |
SELL
Open market or private sale
|
Direct |
10,000
-19.61%
|
$230,000
$23.89 P/Share
|
|
Apr 13
2021
|
Mark A. Velleca |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+16.39%
|
$0
$0.39 P/Share
|